Cohance Life

{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "382.00",
    "chg": 11,
    "chgp": "2.96%",
    "dir": 1,
    "prev_price": "371.00",
    "mcapval": "14,691.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03QK01018",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "3.01 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3817575",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_mojoScore_3817575.png",
        "date": "2026-02-03 10:16:54",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and market performance."
      },
      {
        "title": "Cohance Lifesciences Ltd Opens Strong with Significant Gap Up on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-opens-strong-with-significant-gap-up-on-3-feb-2026-3818181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_gapup_3818181.png",
        "date": "2026-02-03 10:07:18",
        "description": "Cohance Lifesciences Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 5.01% higher than its previous close, signalling a robust start amid positive market conditions in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.355.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-hits-52-week-low-at-rs35565-3816003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_priceRelatedfactors_3816003.png",
        "date": "2026-02-02 09:58:56",
        "description": "Cohance Lifesciences Ltd’s shares declined to a fresh 52-week low of Rs.355.65 on 2 Feb 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its valuation and financial metrics."
      },
      {
        "title": "Cohance Lifesciences Ltd Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-52-week-low-amidst-continued-downtrend-3814750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CohanceLifescie_priceRelatedfactors_3814750.png",
        "date": "2026-02-01 14:07:24",
        "description": "Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.367.35 today, marking a significant decline in its stock price amid broader market volatility and sector underperformance."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.368.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-falls-to-52-week-low-of-rs3685-3807653",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CohanceLifescie_priceRelatedfactors_3807653.png",
        "date": "2026-01-28 11:11:55",
        "description": "Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.368.5 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      },
      {
        "title": "Why is Cohance Lifesciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-cohance-lifesciences-ltd-fallingrising-3806682",
        "imagepath": "",
        "date": "2026-01-28 00:58:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Market Performance</strong></p>\n<p>The stock hit a new 52-week low of ₹369.5 during intraday trading on 27-Jan, marking a significant milestone in its ongoing decline. Over the past week, Cohance Lifesciences has underperformed the benchmark Sensex by a wide margin, with a weekly loss of 6.19% compared to the Sensex’s modest 0.39% decline. This underperformance extends over longer periods as well, with the stock falling 30.25% in the last month and 29.05% year-to-date, while the Sensex has declined by only 3.74% and 3.95% respectively during these intervals.</p>\n<p>More strikingly, the stock has delivered a negative return of 61.68% over the past year, in stark contrast to the Sensex’s gain of 8.61%. Even over three and five years, Cohance Lifesciences has lagged t..."
      },
      {
        "title": "Cohance Lifesciences Ltd Falls to 52-Week Low of Rs.369.5 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-falls-to-52-week-low-of-rs3695-amid-continued-downtrend-3805780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CohanceLifescie_priceRelatedfactors_3805780.png",
        "date": "2026-01-27 10:44:42",
        "description": "Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.369.5 today, marking a significant decline amid broader market pressures and company-specific performance factors."
      },
      {
        "title": "Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.379.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-stock-hits-52-week-low-at-rs37925-3802058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CohanceLifescie_priceRelatedfactors_3802058.png",
        "date": "2026-01-23 14:19:54",
        "description": "Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has declined to a fresh 52-week low of Rs.379.25, marking a significant drop in its share price amid broader market weakness and sector underperformance."
      },
      {
        "title": "Cohance Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-sell-3801309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CohanceLifescie_mojoScore_3801309.png",
        "date": "2026-01-23 10:11:17",
        "description": "Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 500,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "02-Feb-2026",
      "details": "Resignation of Company Secretary and Compliance Officer of the Company w.e.f close of business hours on February 4 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-Jan-2026",
      "details": "Results Conference Call",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "22-Jan-2026",
      "details": "Postal Ballot outcome and voting results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cohance Lifesciences Ltd is Rated Sell

2026-02-03 10:16:54

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the most up-to-date view of the company's fundamentals, returns, and market performance.

Read full news article

Cohance Lifesciences Ltd Opens Strong with Significant Gap Up on 3 Feb 2026

2026-02-03 10:07:18

Cohance Lifesciences Ltd commenced trading on 3 Feb 2026 with a notable gap up, opening 5.01% higher than its previous close, signalling a robust start amid positive market conditions in the Pharmaceuticals & Biotechnology sector.

Read full news article

Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.355.65

2026-02-02 09:58:56

Cohance Lifesciences Ltd’s shares declined to a fresh 52-week low of Rs.355.65 on 2 Feb 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its valuation and financial metrics.

Read full news article

Cohance Lifesciences Ltd Hits 52-Week Low Amidst Continued Downtrend

2026-02-01 14:07:24

Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.367.35 today, marking a significant decline in its stock price amid broader market volatility and sector underperformance.

Read full news article

Cohance Lifesciences Ltd Stock Falls to 52-Week Low of Rs.368.5

2026-01-28 11:11:55

Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.368.5 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Read full news article

Why is Cohance Lifesciences Ltd falling/rising?

2026-01-28 00:58:35

Recent Price Movements and Market Performance

The stock hit a new 52-week low of ₹369.5 during intraday trading on 27-Jan, marking a significant milestone in its ongoing decline. Over the past week, Cohance Lifesciences has underperformed the benchmark Sensex by a wide margin, with a weekly loss of 6.19% compared to the Sensex’s modest 0.39% decline. This underperformance extends over longer periods as well, with the stock falling 30.25% in the last month and 29.05% year-to-date, while the Sensex has declined by only 3.74% and 3.95% respectively during these intervals.

More strikingly, the stock has delivered a negative return of 61.68% over the past year, in stark contrast to the Sensex’s gain of 8.61%. Even over three and five years, Cohance Lifesciences has lagged t...

Read full news article

Cohance Lifesciences Ltd Falls to 52-Week Low of Rs.369.5 Amid Continued Downtrend

2026-01-27 10:44:42

Cohance Lifesciences Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.369.5 today, marking a significant decline amid broader market pressures and company-specific performance factors.

Read full news article

Cohance Lifesciences Ltd Stock Hits 52-Week Low at Rs.379.25

2026-01-23 14:19:54

Cohance Lifesciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has declined to a fresh 52-week low of Rs.379.25, marking a significant drop in its share price amid broader market weakness and sector underperformance.

Read full news article

Cohance Lifesciences Ltd is Rated Sell

2026-01-23 10:11:17

Cohance Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News